Reduced levels of the metabolic hormone leptin may be responsible for poor vaccine efficacy among certain individuals, according to a new study.
An Adelaide-based company has developed a COVID-19 vaccine that completely blocks viral transmission to individuals who lack immunity, as well as offering protection for those inoculated.
Epidyolex has been added to the Pharmaceutical Benefits Scheme (PBS) for the treatment of Dravet syndrome, a rare and drug-resistant form of epilepsy.
The standardised guidelines place pharmacists as key members of the multidisciplinary medical team caring for patients in the ICU.
Researchers at the Cochrane Collaboration reviewed 33 studies involving nearly 5000 participants, relating to antidepressant discontinuation.
SHPA will continue to advocate for investment in embedding geriatric medicine pharmacists as part of clinical pharmacy services for aged-care residents.
Johnson & Johnson Innovation has facilitated a collaboration between WEHI and Janssen Pharmaceutica NV to ignite the development of antimalarial drug candidates.
Australians are being reminded that a causal relationship between blood clotting and adenovirus vector-based vaccines has still not been established, and that — should it be — the risk remains far lower than that of common medications.
This winter, for the first time, a new cell-based flu vaccine will be introduced in Australia, in a bid to boost the efficacy rates of national immunisation programs.
Countries that have opted to pause the AstraZeneca vaccine amid unsubstantiated blood clotting fears are actively choosing to end lives, according to Professor Bruce Thompson.
Whatever the government's intention, Prof Stewart believes a mandate should be the "final instrument" in its quest to roll out a vaccination program.
Australians living with relapsing-remitting multiple sclerosis can now access a new treatment option with the listing of Zeposia (ozanimod) on the PBS.
These days, pharmaceuticals and aged care tend to go hand in hand, but with 95% of aged-care residents living with a medication-induced problem, the relationship is far from harmonious.
Insufficient manufacturing infrastructure and incorrect handling after dispatch are creating supply shortfalls and wastage around the world.
Doctors must now prescribe drugs using their chemical name, not brand names. That's good news for patients.